key: cord-0745859-5yfqslxe
authors: Maru, S.; Patil, U.; Carroll-Bennett, R.; Baum, A.; Bohn-Hemmerdinger, T.; Ditchik, A.; Scanlon, M.; Krishnan, P.; Bogaert, K.; Woodbury, C.; Maru, D.; Noble, L.; Wasserman, R.; Brown, B.; Vreeman, R.; Masci, J.
title: Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York
date: 2020-08-14
journal: nan
DOI: 10.1101/2020.08.12.20171694
sha: 647503cc34474670a2912fa857d0120ab80f88a8
doc_id: 745859
cord_uid: 5yfqslxe

Background Universal screening for SARS-CoV-2 infection on Labor and Delivery (L&D) units is a critical strategy to manage patient and health worker safety, especially in a vulnerable high-prevalence community. We describe the results of a SARS-CoV-2 universal screening program at the L&D Unit at Elmhurst Hospital in Queens, NY, a 545-bed public hospital serving a diverse, largely immigrant and low-income patient population and an epicenter of the global pandemic. Methods and findings We conducted a retrospective cross-sectional study. All pregnant women admitted to the L&D Unit of Elmhurst Hospital from March 29, 2020 to April 22, 2020 were included for analysis. The primary outcomes of the study were: (1) SARS-CoV-2 positivity among universally screened pregnant women, stratified by demographic characteristics, maternal comorbidities, and delivery outcomes; and (2) Symptomatic or asymptomatic presentation at the time of testing among SARS-CoV-2 positive women. A total of 126 obstetric patients were screened for SARS-CoV-2 between March 29 and April 22. Of these, 37% were positive. Of the women who tested positive, 72% were asymptomatic at the time of testing. Patients who tested positive for SARS-CoV-2 were more likely to be of Hispanic ethnicity (unadjusted difference 24.4 percentage points, CI 7.9, 41.0) and report their primary language as Spanish (unadjusted difference 32.9 percentage points, CI 15.8, 49.9) than patients who tested negative. Conclusions In this retrospective cross-sectional study of data from a universal SARS-Cov-2 screening program implemented in the L&D unit of a safety-net hospital in Queens, New York, we found over one-third of pregnant women testing positive, the majority of those asymptomatic. The rationale for universal screening at the L&D Unit at Elmhurst Hospital was to ensure safety of patients and staff during an acute surge in SARS-Cov-2 infections through appropriate identification and isolation of pregnant women with positive test results. Women were roomed by their SARS-CoV-2 status given increasing space limitations. In addition, postpartum counseling was tailored to infection status. We quickly established discharge counseling and follow-up protocols tailored to their specific social needs. The experience at Elmhurst Hospital is instructive for other L&D units serving vulnerable populations and for pandemic preparedness.

Background 36 Universal screening for SARS-CoV-2 infection on Labor and Delivery (L&D) 37

units is a critical strategy to manage patient and health worker safety, especially in a 38 vulnerable high-prevalence community. We describe the results of a SARS- universal screening program at the L&D Unit at Elmhurst Hospital in Queens, NY, a 545-40 bed public hospital serving a diverse, largely immigrant and low-income patient 41

population and an epicenter of the global pandemic. 42 43

Methods and findings 44 We conducted a retrospective cross-sectional study. All pregnant women admitted 45

to the L&D Unit of Elmhurst Hospital from March 29, 2020 to April 22, 2020 were 46 included for analysis. The primary outcomes of the study were: (1) SARS-CoV-2 47 positivity among universally screened pregnant women, stratified by demographic 48 characteristics, maternal comorbidities, and delivery outcomes; and (2) Symptomatic or 49 asymptomatic presentation at the time of testing among SARS-CoV-2 positive women. 50

A total of 126 obstetric patients were screened for SARS-CoV-2 between March 51 29 and April 22. Of these, 37% were positive. Of the women who tested positive, 72% 52

were asymptomatic at the time of testing. Patients who tested positive for SARS-CoV-2 53

were more likely to be of Hispanic ethnicity (unadjusted difference 24.4 percentage 54 points, CI 7.9, 41.0) and report their primary language as Spanish (unadjusted difference 55 32.9 percentage points, CI 15.8, 49.9) than patients who tested negative. 56 57

In this retrospective cross-sectional study of data from a universal SARS-Cov-2 59 screening program implemented in the L&D unit of a safety-net hospital in Queens, New 60 York, we found over one-third of pregnant women testing positive, the majority of those 61 asymptomatic. Forty-six of 124 (37.1%) screened pregnant women had a positive SARS-CoV-2 160 test. Of those, 33 (71.7%) were asymptomatic and 13 (28.3%) were symptomatic (Fig 1) . 161

Of those women who were symptomatic, the median number of symptoms on admission 162 was 2, with the most common symptoms fever and cough. Other symptoms that were 163 reported by patients in this cohort included body aches, sore throat, shortness of breath or 164 difficulty breathing, headache, and runny nose. The presence of symptoms did not appear 165 to be related to the mode of delivery or associated with preterm delivery. Of note, during 166 our study period there were no maternal deaths. 167 The cross-sectional association we observed between test-positivity and Hispanic 213 ethnicity and Spanish as a primary language may be confounded by patients' 214 socioeconomic status. At Elmhurst Hospital we serve a largely immigrant (foreign-born), 215 resource-poor population. The primary language of Spanish likely indicates the patient 216 was not born in the USA or is a first-degree descendant of Latin American immigrants 217 (although there may be exceptions). Both of these characteristics are common in our 218 patient population. Additionally, Spanish as a preferred language may indicate barriers to 219 seeking or utilizing healthcare, which may affect co-morbidities and infection rates. 220

When looking at mode of delivery and gestational age at delivery, no significant 221 difference in either of these was noted between the SARS-CoV-2 positive and negative 222 mothers. SARS-CoV-2 status was not an indication for cesarean section or for preterm 223 induction of labor. 224

The increased length of stay in the symptomatic patients is likely secondary to the 225 severity of illness being greater in symptomatic patients. In order to warrant admission 226 for SARS-Cov-2 symptoms typically maternal fever had to be accompanied by either 227 maternal or fetal tachycardia, shortness of breath or decreased oxygen saturation on room 228 air, or concerning findings on chest X-ray for possible pneumonia. Patients who did not 229 meet these criteria, and had normal vital signs apart from fever, and reassuring fetal 230 testing were typically assessed in our triage area and discharged home rather than 231 admitted. These patients who were not admitted would not have been included in this 232 cohort. The criteria for discharge among symptomatic patients included normalization of 233 vital signs, specifically remaining afebrile and having oxygen saturation of over 95% 234 consistently on room air both at rest and with ambulation. 235

Our first Obstetric SARS-CoV-2 case was March 15. Early in the pandemic, when 236 we tested based on symptoms and history alone, several obstetric patients were admitted 237 for birth asymptomatic and were later readmitted with severe COVID-19 infection. We 238 were concerned about the likely spread to staff and other patients within our unit from 239 pre-symptomatic and asymptomatic women. At the same time, our hospital was quickly 240 becoming the epicenter of cases in the US, and all available physical space was required 241 to care for COVID-19 patients. A large part of the postpartum unit was needed for non-242 obstetric COVID-19 care, and we suddenly had limited capacity to isolate positive 243 postpartum women and those with unknown status. Upon this structural change, we 244 began universal screening of pregnant women with planned or unplanned admission. One 245 limitation of our study was the use of two different test types for universal screening. We 246 were initially using BioReference Laboratory tests which returned in several days, and as 247 rapid tests became available we switched to the Cepheid Rapid PCR. These tests likely 248 had different sensitivities and specificities (though we were not provided with this 249 information) and may have affected our screening results. 250 SARS-CoV-2 screening fundamentally shifted the way we roomed, counseled, 251 and followed women (Fig 2) . Cohorting women by SARS-CoV-2 infection status allowed 252 us to most safely use the restricted space. Several walls were built to further partition the 253 space in the triage, labor, and postpartum areas in order to ensure separation of SARS-254

CoV-2 positive women and those of unknown status from women known to be negative.

In the early days of the pandemic, SARS-CoV-2 positive mothers were roomed 256 separately from their infants, however, this procedure was reconsidered as the volume of 257 known SARS-CoV-2 positive mothers increased with universal screening. Given limited 258 physical space and staff to isolate all infants and considering the importance of 259 simulating the home-environment during the postpartum hospitalization to promote safe 260 infant care and breastfeeding, we proceeded with shared decision making with SARS- We found high rates of asymptomatic SARS-CoV-2 infection among pregnant 278 women; these screening data and our experience at a large public hospital at the epicenter of the nation's pandemic are instructive. In future epidemics, it may be prudent to look at 280 L&D screening numbers early on, as pregnant women continue to seek essential care 281 despite social distancing measures and also represent the general young and healthy 282 community population. Additionally, this experience illustrates a nimble response to an 283 acute shortage of space and PPE for hard-hit vulnerable communities. 

The lost 305 month: How a failure to test blinded the U.S. to Covid-19. The New York Times

Estimating the asymptomatic 312 proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond 313 Princess cruise ship

Characteristics and Outcomes of 241 318 Births to Women With Severe Acute Respiratory Syndrome Coronavirus

Infection at Five New York City Medical Centers

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in 323 Pregnancy

Testing of Patients and Support Persons 325 for Coronavirus Disease 2019 (COVID-19) Infection Before Scheduled Deliveries

Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection

New York: NYC Health + Hospitals, 331 OneCity Health

13 deaths in a day: an 334 'apocalyptic' coronavirus surge at an NYC hospital. The New York Times

Universal Screening for SARS-CoV-340 2 in Women Admitted for Delivery

344 Screening all pregnant women admitted to Labor and Delivery for the virus responsible 345 for COVID-19

NYC Housing Brief: Hidden Households. Office of the New York 348 City Comptroller